Skip to Content


Active Substance: sildenafil
Common Name: sildenafil
ATC Code: G04BE03
Marketing Authorisation Holder: Pfizer Limited
Active Substance: sildenafil
Status: Withdrawn
Authorisation Date: 1998-09-15
Therapeutic Area: Erectile Dysfunction
Pharmacotherapeutic Group: Urologicals

Therapeutic Indication

Treatment of men with erectile dysfunction, which is the inability to achieve or maintain a penile
erection sufficient for satisfactory sexual performance.
In order for Patrex to be effective, sexual stimulation is required.
PATREX is not indicated for use by women.

The marketing authorisation for Patrex has not been renewed by the marketing authorisation holder and is now withdrawn.

Source: European Medicines Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.